add share buttons
Arizonas Finest Lawyers

Everything you need to know About Taxotere Lawsuits

When you have been diagnosed with cancers or know someone who has been diagnosed with cancer, chances are you have heard about the drug Taxotere. The drug is manufactured and marketed by the company Sanofi-Aventis was first approved by the FDA in 1996.

The drug that they manufacture, Taxotere, is a popular drug found in chemotherapy across the United States. Specifically, it is utilized in the majority of breast cancer treatments, as well as other forms of cancer. Taxotere is administered intravenously and is meant to slow the cancer cell growth in patients.

When Taxotere first became available, it was the go-to treatment for women with breast cancer. Approximately 75% of breasts cancer patients were approved Taxotere to fight the growth of cancer. Chemotherapy is never a fun thing for anyone, but Taxotere made chemotherapy even harder on hundreds of thousands of women. To get more information regarding taxotere lawsuit, you can also search online.

As you also may be aware of, chemotherapy and Taxotere are combined by some pretty detrimental side results. Some common side effects include your typical nausea, vomiting, fatigue, pain, etc. Also, one of the most common side effects that are associated with chemotherapy is hair loss.

Many chemotherapy patients will experience some type of hair loss while being administered Taxotere. Although this is common in chemotherapy, Taxotere is associated with the permanent loss of hair without the ability to grow back post-chemotherapy.

This permanent hair loss is a very unexpected and serious result of the drug Taxotere. The condition of permanent hair loss as a result of Taxotere is referred to “alopecia.” Alopecia can have a severely adverse effect on the morale of the patient, as well as the patient’s families.

As a result, many patients were being administered Taxotere without their knowledge that they may be at risk for permanent loss of hair. In 2015, the FDA issued a warning statement that “cases of permanent alopecia have been reported” after being administered Taxotere.

The last thing a cancer patient and their family need after the conclusion of chemotherapy is a constant reminder of the horrible symptoms and fear experienced by the permanent hair loss of a patient.